AboutContact usRSS
dotsbydots
SEARCHCONTACT US

Buzz

Most popular

Daily
Weekly
1
Insight Partners hit by cyber attack with possible data leaks
2
CyberArk’s surge, Wiz and Cato prepare for IPOs: Israeli cyber firms ready for the next big move
3
Cybereason CEO accuses Mnuchin, SoftBank of forcing company toward bankruptcy
4
Riskified cuts staff as struggles continue
5
Israel-China tech ties persist amid political tensions
More news

Migraine

11 stories about Migraine
Theranica

Theranica secures $45 million Series C to treat migraines

29.08.22|CTech
The Israeli company has developed an FDA-cleared, smartphone-controlled, drug-free wearable device named Nerivio for the treatment of episodic and chronic migraine
קור שולץ מנכ"ל טבע 9.11.19

Teva Receives FDA Approval for Migraine Autoinjector

29.01.20|Sophie Shulman
Teva’s anti-migraine injection was approved in late 2018 but struggled to establish a market share due to both Amgen and Eli Lilly offering a similar drug with an autoinjector
אתר טבע כפר סבא

Teva’s Israeli Plant Receives FDA Stamp of Approval for Migraine Drug Manufacturing

17.11.19|Navit Zomer
The Israeli drugmaker’s manufacturing facility in Kfar Saba, already experienced with manufacturing cash cow Copaxone, will oversee the process of filling the syringes with the biological drug and also conduct quality control tests
מוסף כאב ראש מיגרנה

This Headset Could Treat Migraines

14.07.19|Lilach Baumer
Israel-based Neurolief has recently received European approval for its noninvasive, adjustable electronic headset, which uses nerve stimulation to control pain
אתר טבע כפר סבא

Teva Discontinues Development of Cluster Headache Drug

24.04.19|Tzally Greenberg
Under Teva’s brand name Ajovy, fremanezumab has already been approved in the U.S. and Europe as a preventative migraine treatment
מנכ"ל טבע קאר שולץ קור שולץ קר שולץ מנכ"ל טבע פברואר 2018

Market Indifferent to European Approval of Teva's Migraine Drug

02.04.19|Lilach Baumer
Teva's injection, one of three similar migraine drugs already approved in the U.S., is the third to receive European approval after Amgen Inc. and Novartis AG and Eli Lilly
מוסף כאב ראש מיגרנה

Migraine Treatment Startup Theranica Raises $35 Million

18.03.19|Adi Pick
Theranica develops electrical nerve stimulation (ENS) technology for controlling migraines
מנכ"ל טבע החדש קור שולץ 2

CVS Picks Migraine Drugs by Teva, Eli Lilly, Snubs Amgen, Reuters Reports

27.01.19|Lilach Baumer
In October, American prescription benefits management company Express Scripts added Amgen and Eli Lilly’s drugs to its coverage but excluded Teva
מנכ"ל טבע החדש קור שולץ 1

U.S. Benefit Manager Express Scripts Snubs Teva Migraine Injection, Report Says

18.10.18|Lilach Baumer
A Wednesday Reuters report revealed the U.S. company will cover drugs by Eli Lilly and Amgen, but not by Teva
קאר שולץ מנכל טבע

Teva Shares Rise Following FDA Approval of Migraine Drug

16.09.18|Dror Reich
Teva’s new migraine drug is forecasted to bring in $500 million in sales annually
יצחק פטרבורג

Teva Submits Potential Moneymaker Migraine Drug for FDA Approval

18.10.17|Dror Reich and Lilach Baumer
Teva’s patent for its moneymaker multiple sclerosis drug Copaxone expired last year